Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
46.27
-1.79 (-3.72%)
At close: Jul 24, 2026, 4:00 PM EDT
46.01
-0.26 (-0.56%)
After-hours: Jul 24, 2026, 7:57 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Single Cell Instruments Revenue
21.98M22.67M35.21M
Spatial Instruments Revenue
31.25M34.11M57.50M
Total Instruments Revenue
53.23M56.78M92.72M
Single Cell Consumables Revenue
367.99M363.21M372.31M
Spatial Consumables Revenue
153.64M143.98M121.12M
Total Consumables Revenue
521.63M507.18M493.43M
Services Revenue
33.91M32.73M24.32M
License and Royalty Revenue
30.02M46.14M321.00K
Revenue (Total)
638.78M642.82M610.79M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States Revenue
336.39M346.51M334.32M
North America (ex-United States) Revenue
11.92M12.26M13.45M
Europe, Middle East and Africa Revenue
166.67M161.72M159.76M
China Revenue
69.22M70.26M57.30M
Asia-Pacific (ex-China) Revenue
54.59M52.07M45.96M
Revenue (Total)
638.78M642.82M610.79M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cumulative Instruments Sold
8.05K7.04K
Total Consumables Reactions Sold
424.00K357.10K